Practical information
A "Les Jeudis de l'Ifri" videoconférence around Laurence NARDON, head of Ifri's North America program.
While healthcare remains unaffordable for many US citizens, the congress, administration, and federal states are addressing the coronavirus epidemic. In the midst of the electoral campaign, this crisis seems to result in a form of national unity. Is it beneficial for President Trump? What are the chances for his rival Joe Biden? On the international stage, Washington's response is awaited as Beijing seeks to impose its triumphant narrative.
Chair : Thomas Gomart, director of Ifri.
This debate is for corporate members only. It will be conducted in French.
Listen to Laurence Nardon's podcast for Slate on "Face au coronavirus, les inquiétantes réactions de Trump" (In French)
Listen to Laurence Nardon's podcast for Slate on "Le système de santé américain face au coronavirus" (In French)
Speakers
Related Subjects
Other events
The Future of Space Cooperation: Challenges and Opportunities in the Trump II Era
The policy orientations of the Trump II administration profoundly challenge the foundations of international cooperation in space science and exploration. This shift reflects a broader trend of strategic disengagement and weakening of multilateral mechanisms in the space domain.
Strategic Autonomy and Asia amid Rising Geoeconomic Competition
Amid growing strategic and geopolitical uncertainty, Europe is grappling with the notion of its strategic autonomy. For Europe’s partners in Asia, the concept is also becoming increasingly salient as the world enters an era of structural transformation.
France-Germany, The Engine Under Pressure
Faced with a profoundly disrupted strategic and economic environment, Franco-German cooperation is more than ever the central pillar of Europe's future. The war in Ukraine, energy and technological dependence, and uncertainty about the strength of the transatlantic ties require urgent deepening of European sovereignty, both in terms of defence and economic and industrial competitiveness.